Owing to the risks associated with craniotomies and CNS biopsies, it is difficult to obtain and study brain tissue from humans with advanced EGFR-mutant NSCLC, especially in those patients with CNS disease that developed after metastases appeared elsewhere in the body. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.